Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Clinical trial NCT03454035 · RECRUITING
Trial details
- NCT number
- NCT03454035
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-30
- Primary completion
- 2026-07-15
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.